Literature DB >> 8336379

Lessons from France--'vive la différence'. The French health care system and US health system reform.

J E Fielding1, P J Lancry.   

Abstract

Mesh：

Year:  1993        PMID： 8336379     DOI： 10.1001/jama.270.6.748

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  A model to compute the medical cost of patients in intensive care.

Authors:  C Chaix; I Durand-Zaleski; C Alberti; C Brun-Buisson
Journal:  Pharmacoeconomics       Date:  1999-06       Impact factor: 4.981

2.  The promotion of generalism in medicine: renaissance or recycling?

Authors:  J L Wofford; M C Wilson; W P Moran
Journal:  J Gen Intern Med       Date:  1994-12       Impact factor: 5.128

3.  Costs for acute myocardial infarction in a tertiary care centre and nationwide in France.

Authors:  O Montagne; C Chaix; A Harf; A Castaigne; I Durand-Zaleski
Journal:  Pharmacoeconomics       Date:  2000-06       Impact factor: 4.981

4.  Agreement of four competing guidelines on prevention of venous thromboembolism and comparison with observed physician practices: a cross-sectional study of 1,032 medical inpatients.

Authors:  José Labarère; Jean-Luc Bosson; Jean-François Bergmann; Nathalie Thilly
Journal:  J Gen Intern Med       Date:  2004-08       Impact factor: 5.128

5.  Western impressions of the Hong Kong health care system.

Authors:  C L Bennett; G K Pei; J E Ultmann
Journal:  West J Med       Date:  1996 Jul-Aug

Review 6.  Why buprenorphine is so successful in treating opiate addiction in France.

Authors:  M Fatseas; Marc Auriacombe
Journal:  Curr Psychiatry Rep       Date:  2007-10       Impact factor: 5.285

Review 7.  Preventive health care in six countries: models for reform?

Authors:  C P Chaulk
Journal:  Health Care Financ Rev       Date:  1994

8.  The contribution of open comments to understanding the results from the Hospital Survey on Patient Safety Culture (HSOPS): A qualitative study.

Authors:  Bastien Boussat; Kevin Kamalanavin; Patrice François
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.